Bonesupport stock rises as Cerament study published in NEJM

Bonesupport's Solario study on its antibiotic-releasing bone substitute Cerament was published in NEJM, driving a stock gain at Thursday's open. The publication is a positive validation of the product's efficacy, but the market impact is limited to the company's shares. The study's results are not detailed in the item, so the magnitude of the clinical benefit remains unclear.